Literature DB >> 33732644

Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma.

Wenjie Zhou1,2, Junqing Li1,2, Xiaofang Lu3, Fangjie Liu4, Tailai An1, Xing Xiao5, Zi Chong Kuo1, Wenhui Wu1, Yulong He1,2.   

Abstract

As a CRISPR-Cas9-based tool to help scientists to investigate gene functions, Cancer Dependency Map genes (CDMs) include an enormous series of loss-of-function screens based on genome-scale RNAi. These genes participate in regulating survival and growth of tumor cells, which suggests their potential as novel therapeutic targets for malignant tumors. By far, studies on the roles of CDMs in gastric adenocarcinoma (GA) are scarce and only a small fraction of CDMs have been investigated. In the present study, datasets of the differentially expressed genes (DEGs) were extracted from the TCGA-based (The Cancer Genome Atlas) GEPIA database, from which differentially expressed CDMs were determined. Functions and prognostic significance of these verified CDMs were evaluated using a series of bioinformatics methods. In all, 246 differentially expressed CDMs were determined, with 147 upregulated and 99 downregulated. Ten CDMs (ALG8, ATRIP, CCT6A, CFDP1, CINP, MED18, METTL1, ORC1, TANGO6, and PWP2) were identified to be prognosis-related and subsequently a prognosis model based on these ten CDMs was constructed. In comparison with that of patients with low risk in TCGA training, testing and GSE84437 cohort, overall survival (OS) of patients with high risk was significantly worse. It was then subsequently demonstrated that for this prognostic model, area under the ROC (receiver operating characteristic) curve was 0.771 and 0.697 for TCGA training and testing cohort respectively, justifying its reliability in predicting survival of GA patients. With the ten identified CDMs, we then constructed a nomogram to generate a clinically practical model. The regulatory networks and functions of the ten CDMs were then explored, the results of which demonstrated that as the gene significantly associated with survival of GA patients and Hazard ratio (HR), PWP2 promoted in-vitro invasion and migration of GA cell lines through the EMT signaling pathway. Therefore, in conclusion, the present study might help understand the prognostic significance and molecular functions of CDMs in GA.
Copyright © 2021 Zhou, Li, Lu, Liu, An, Xiao, Kuo, Wu and He.

Entities:  

Keywords:  Cancer Dependency Map; TCGA; gastric adenocarcinoma; invasion and metastasis; prognostic model

Year:  2021        PMID: 33732644      PMCID: PMC7959733          DOI: 10.3389/fonc.2021.617289

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  42 in total

Review 1.  Basics of DNA biosensors and cancer diagnosis.

Authors:  Nasrin Sohrabi; Alireza Valizadeh; Samad Mussa Farkhani; Abolfazl Akbarzadeh
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-11-13       Impact factor: 5.678

2.  Defining a Cancer Dependency Map.

Authors:  Aviad Tsherniak; Francisca Vazquez; Phil G Montgomery; Barbara A Weir; Gregory Kryukov; Glenn S Cowley; Stanley Gill; William F Harrington; Sasha Pantel; John M Krill-Burger; Robin M Meyers; Levi Ali; Amy Goodale; Yenarae Lee; Guozhi Jiang; Jessica Hsiao; William F J Gerath; Sara Howell; Erin Merkel; Mahmoud Ghandi; Levi A Garraway; David E Root; Todd R Golub; Jesse S Boehm; William C Hahn
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

3.  Localization of ORC1 during the cell cycle in human leukemia cells.

Authors:  Frederick D Coffman; Mai-Ling Reyes; Monique Brown; W Clark Lambert; Stanley Cohen
Journal:  Anal Cell Pathol (Amst)       Date:  2011       Impact factor: 2.916

Review 4.  DNA repair targeted therapy: The past or future of cancer treatment?

Authors:  Navnath S Gavande; Pamela S VanderVere-Carozza; Hilary D Hinshaw; Shadia I Jalal; Catherine R Sears; Katherine S Pawelczak; John J Turchi
Journal:  Pharmacol Ther       Date:  2016-02-16       Impact factor: 12.310

5.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

Review 6.  Progress in the treatment of advanced gastric cancer.

Authors:  Zheyu Song; Yuanyu Wu; Jiebing Yang; Dingquan Yang; Xuedong Fang
Journal:  Tumour Biol       Date:  2017-07

7.  The Drug Repurposing Hub: a next-generation drug library and information resource.

Authors:  Steven M Corsello; Joshua A Bittker; Zihan Liu; Joshua Gould; Patrick McCarren; Jodi E Hirschman; Stephen E Johnston; Anita Vrcic; Bang Wong; Mariya Khan; Jacob Asiedu; Rajiv Narayan; Christopher C Mader; Aravind Subramanian; Todd R Golub
Journal:  Nat Med       Date:  2017-04-07       Impact factor: 53.440

8.  High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.

Authors:  Channing Yu; Aristotle M Mannan; Griselda Metta Yvone; Kenneth N Ross; Yan-Ling Zhang; Melissa A Marton; Bradley R Taylor; Andrew Crenshaw; Joshua Z Gould; Pablo Tamayo; Barbara A Weir; Aviad Tsherniak; Bang Wong; Levi A Garraway; Alykhan F Shamji; Michelle A Palmer; Michael A Foley; Wendy Winckler; Stuart L Schreiber; Andrew L Kung; Todd R Golub
Journal:  Nat Biotechnol       Date:  2016-02-29       Impact factor: 54.908

9.  Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.

Authors:  Jiahui Xu; Deying Liu; Huilin Niu; Guifang Zhu; Yangwei Xu; Danli Ye; Jian Li; Qingling Zhang
Journal:  J Exp Clin Cancer Res       Date:  2017-01-26

10.  gganatogram: An R package for modular visualisation of anatograms and tissues based on ggplot2.

Authors:  Jesper L V Maag
Journal:  F1000Res       Date:  2018-09-28
View more
  7 in total

Review 1.  Novel roles of METTL1/WDR4 in tumor via m7G methylation.

Authors:  Wenli Cheng; Aili Gao; Hui Lin; Wenjuan Zhang
Journal:  Mol Ther Oncolytics       Date:  2022-06-07       Impact factor: 6.311

2.  Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.

Authors:  Shenghan Lou; Fanzheng Meng; Xin Yin; Yao Zhang; Bangling Han; Yingwei Xue
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

Review 3.  The potential role of N7-methylguanosine (m7G) in cancer.

Authors:  Yuejun Luo; Yuxin Yao; Peng Wu; Xiaohui Zi; Nan Sun; Jie He
Journal:  J Hematol Oncol       Date:  2022-05-19       Impact factor: 23.168

Review 4.  Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models.

Authors:  Michela Pucci; Martina Duca; Nadia Malagolini; Fabio Dall'Olio
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

5.  Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma.

Authors:  Yixi Li; Dehua Li; Yang Chen; Yongping Lu; Fangbin Zhou; Chunhong Li; Zhipeng Zeng; Wanxia Cai; Liewen Lin; Qiang Li; Mingjun Ye; Jingjing Dong; Lianghong Yin; Donge Tang; Gong Zhang; Yong Dai
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

6.  Expression and Clinical Significance of Origin Recognition Complex Subunit 6 in Breast Cancer - A Comprehensive Bioinformatics Analysis.

Authors:  Shaohua Chen; Ziyao Jin; Linfeng Xin; Lv Lv; Xuemei Zhang; Yizhen Gong; Jianlun Liu
Journal:  Int J Gen Med       Date:  2021-12-14

7.  Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning.

Authors:  Chen Zhao; Kewei Xiong; Fangrui Zhao; Abdalla Adam; Xiangpan Li
Journal:  Oxid Med Cell Longev       Date:  2022-03-04       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.